Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 121826, 14 pages
http://dx.doi.org/10.1155/2015/121826
Review Article

Roles of Autophagy Induced by Natural Compounds in Prostate Cancer

V. Naponelli,1,2,3 A. Modernelli,1,2 S. Bettuzzi,1,2,3 and F. Rizzi1,2,3

1Department of Biomedicine, Biotechnology and Translational Research, University of Parma, Via Volturno 39/a, 43125 Parma, Italy
2Centre for Molecular and Translational Oncology (COMT), University of Parma, Parco Area delle Scienze 11/a, 43124 Parma, Italy
3National Institute of Biostructure and Biosystems (INBB), Viale Medaglie d’Oro 305, 00136 Rome, Italy

Received 9 July 2014; Accepted 23 December 2014

Academic Editor: Arkadiusz Orzechowski

Copyright © 2015 V. Naponelli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Ferlay, E. Steliarova-Foucher, J. Lortet-Tieulent et al., “Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012,” European Journal of Cancer, vol. 49, no. 6, pp. 1374–1403, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. A. J. Meijer and P. Codogno, “Regulation and role of autophagy in mammalian cells,” International Journal of Biochemistry and Cell Biology, vol. 36, no. 12, pp. 2445–2462, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Mariño, M. Niso-Santano, E. H. Baehrecke, and G. Kroemer, “Self-consumption: the interplay of autophagy and apoptosis,” Nature Reviews Molecular Cell Biology, vol. 15, no. 2, pp. 81–94, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Levine and G. Kroemer, “Autophagy in the pathogenesis of disease,” Cell, vol. 132, no. 1, pp. 27–42, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Mizushima, T. Yoshimori, and Y. Ohsumi, “The role of atg proteins in autophagosome formation,” Annual Review of Cell and Developmental Biology, vol. 27, pp. 107–132, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Itakura and N. Mizushima, “Characterization of autophagosome formation site by a hierarchical analysis of mammalian Atg proteins,” Autophagy, vol. 6, no. 6, pp. 764–776, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. J. L. Webber and S. A. Tooze, “New insights into the function of Atg9,” FEBS Letters, vol. 584, no. 7, pp. 1319–1326, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. R. C. Russell, H. X. Yuan, and K. L. Guan, “Autophagy regulation by nutrient signaling,” Cell Research, vol. 24, no. 1, pp. 42–57, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. L. L. Fu, Y. Cheng, and B. Liu, “Beclin-1: autophagic regulator and therapeutic target in cancer,” International Journal of Biochemistry and Cell Biology, vol. 45, no. 5, pp. 921–924, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Kang, H. J. Zeh, M. T. Lotze, and D. Tang, “The Beclin 1 network regulates autophagy and apoptosis,” Cell Death and Differentiation, vol. 18, no. 4, pp. 571–580, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Zalckvar, H. Berissi, M. Eisenstein, and A. Kimchi, “Phosphorylation of Beclin 1 by DAP-kinase promotes autophagy by weakening its interactions with Bcl-2 and Bcl-XL,” Autophagy, vol. 5, no. 5, pp. 720–722, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. R. C. Wang, Y. Wei, Z. An et al., “Akt-mediated regulation of autophagy and tumorigenesis through Beclin 1 phosphorylation,” Science, vol. 338, no. 6109, pp. 956–959, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Wei, S. Pattingre, S. Sinha, M. Bassik, and B. Levine, “JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy,” Molecular Cell, vol. 30, no. 6, pp. 678–688, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Jiang, D. Cheng, W. Liu, J. Peng, and J. Feng, “Protein kinase C inhibits autophagy and phosphorylates LC3,” Biochemical and Biophysical Research Communications, vol. 395, no. 4, pp. 471–476, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. S. J. Cherra III, S. M. Kulich, G. Uechi et al., “Regulation of the autophagy protein LC3 by phosphorylation,” The Journal of Cell Biology, vol. 190, no. 4, pp. 533–539, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. E. White and R. S. DiPaola, “The double-edged sword of autophagy modulation in cancer,” Clinical Cancer Research, vol. 15, no. 17, pp. 5308–5316, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Shintani and D. J. Klionsky, “Autophagy in health and disease: a double-edged sword,” Science, vol. 306, no. 5698, pp. 990–995, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Lozy and V. Karantza, “Autophagy and cancer cell metabolism,” Seminars in Cell and Developmental Biology, vol. 23, no. 4, pp. 395–401, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Degenhardt, R. Mathew, B. Beaudoin et al., “Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis,” Cancer Cell, vol. 10, no. 1, pp. 51–64, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. V. Karantza-Wadsworth, S. Patel, O. Kravchuk et al., “Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis,” Genes and Development, vol. 21, no. 13, pp. 1621–1635, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. K. N. Dalby, I. Tekedereli, G. Lopez-Berestein, and B. Ozpolat, “Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer,” Autophagy, vol. 6, no. 3, pp. 322–329, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Maycotte and A. Thorburn, “Autophagy and cancer therapy,” Cancer Biology and Therapy, vol. 11, no. 2, pp. 127–137, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Boya, R. A. González-Polo, N. Casares et al., “Inhibition of macroautophagy triggers apoptosis,” Molecular and Cellular Biology, vol. 25, no. 3, pp. 1025–1040, 2005. View at Publisher · View at Google Scholar
  24. X. Qu, J. Yu, G. Bhagat et al., “Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene,” The Journal of Clinical Investigation, vol. 112, no. 12, pp. 1809–1820, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. V. M. Aita, X. H. Liang, V. V. V. S. Murty et al., “Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21,” Genomics, vol. 59, no. 1, pp. 59–65, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. Z. Yue, S. Jin, C. Yang, A. J. Levine, and N. Heintz, “Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 25, pp. 15077–15082, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Takahashi, T. Hori, T. K. Cooper et al., “Bif-1 haploinsufficiency promotes chromosomal instability and accelerates Myc-driven lymphomagenesis via suppression of mitophagy,” Blood, vol. 121, no. 9, pp. 1622–1632, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Mathew, C. M. Karp, B. Beaudoin et al., “Autophagy suppresses tumorigenesis through elimination of p62,” Cell, vol. 137, no. 6, pp. 1062–1075, 2009. View at Publisher · View at Google Scholar
  29. G. Mariño, N. Salvador-Montoliu, A. Fueyo, E. Knecht, N. Mizushima, and C. López-Otín, “Tissue-specific autophagy alterations and increased tumorigenesis in mice deficient in Atg4C/autophagin-3,” The Journal of Biological Chemistry, vol. 282, no. 25, pp. 18573–18583, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. Z. Zhao, S. Oh, D. Li et al., “A dual role for UVRAG in maintaining chromosomal stability independent of autophagy,” Developmental Cell, vol. 22, no. 5, pp. 1001–1016, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Eisenberg-Lerner and A. Kimchi, “The paradox of autophagy and its implication in cancer etiology and therapy,” Apoptosis, vol. 14, no. 4, pp. 376–391, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. M. T. Rosenfeldt, J. O'Prey, J. P. Morton et al., “P53 status determines the role of autophagy in pancreatic tumour development,” Nature, vol. 504, no. 7479, pp. 296–300, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Mathew, V. Karantza-Wadsworth, and E. White, “Role of autophagy in cancer,” Nature Reviews Cancer, vol. 7, no. 12, pp. 961–967, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Phin, M. W. Moore, and P. D. Cotter, “Genomic rearrangements of PTEN in prostate cancer,” Frontiers in Oncology, vol. 3, p. 240, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. X. Gao, A. Zacharek, A. Salkowski et al., “Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer,” Cancer Research, vol. 55, no. 5, pp. 1002–1005, 1995. View at Google Scholar · View at Scopus
  36. J. P. Elo, P. Härkönen, A. P. Kyllönen et al., “Loss of heterozygosity at 16q24.1-q24.2 is significantly associated with metastatic and aggressive behavior of prostate cancer,” Cancer Research, vol. 57, no. 16, pp. 3356–3359, 1997. View at Google Scholar · View at Scopus
  37. C. Liu, P. Xu, D. Chen et al., “Roles of autophagy-related genes Beclin-1 and LC3 in the development and progression of prostate cancer and benign prostatic hyperplasia,” Biomedical Reports, vol. 1, no. 6, pp. 855–860, 2013. View at Publisher · View at Google Scholar
  38. A. Giatromanolaki, E. Sivridis, S. Mendrinos, A. V. Koutsopoulos, and M. I. Koukourakis, “Autophagy proteins in prostate cancer: relation with anaerobic metabolism and Gleason score,” Urologic Oncology: Seminars and Original Investigations, vol. 32, no. 1, pp. 39.e11–39.e18, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Herman-Antosiewicz, D. E. Johnson, and S. V. Singh, “Sulforaphane causes autophagy to inhibit release of cytochrome C and apoptosis in human prostate cancer cells,” Cancer Research, vol. 66, no. 11, pp. 5828–5835, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. A. R. Vyas, E.-R. Hahm, J. A. Arlotti et al., “Chemoprevention of prostate cancer by d,l-sulforaphane is augmented by pharmacological inhibition of autophagy,” Cancer Research, vol. 73, no. 19, pp. 5985–5995, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. D. Xiao, A. A. Powolny, J. Antosiewicz et al., “Cellular responses to cancer chemopreventive agent D,L-sulforaphane in human prostate cancer cells are initiated by mitochondrial reactive oxygen species,” Pharmaceutical Research, vol. 26, no. 7, pp. 1729–1738, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. J. F. Lin, T. F. Tsai, P. C. Liao et al., “Benzyl isothiocyanate induces protective autophagy in human prostate cancer cells via inhibition of mTOR signaling,” Carcinogenesis, vol. 34, no. 2, pp. 406–414, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. D. Xiao, A. A. Powolny, M. B. Moura et al., “Phenethyl isothiocyanate inhibits oxidative phosphorylation to trigger reactive oxygen species-mediated death of human prostate cancer cells,” Journal of Biological Chemistry, vol. 285, no. 34, pp. 26558–26569, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Bommareddy, E.-R. Hahm, D. Xiao et al., “Atg5 regulates Phenethyl isothiocyanate-lnduced autophagic and apoptotic cell death in human prostate cancer cells,” Cancer Research, vol. 69, no. 8, pp. 3704–3712, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. A. A. Powolny, A. Bommareddy, E.-R. Hahm et al., “Chemopreventative potential of the cruciferous vegetable constituent phenethyl isothiocyanate in a mouse model of prostate cancer,” Journal of the National Cancer Institute, vol. 103, no. 7, pp. 571–584, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. G. Li, P. Rivas, R. Bedolla et al., “Dietary resveratrol prevents development of high-grade prostatic intraepithelial neoplastic lesions: Involvement of SIRT1/S6K axis,” Cancer Prevention Research, vol. 6, no. 1, pp. 27–39, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. F. Rizzi, V. Naponelli, A. Silva et al., “Polyphenon E, a standardized green tea extract, induces endoplasmic reticulum stress, leading to death of immortalized PNT1a cells by anoikis and tumorigenic PC3 by necroptosis,” Carcinogenesis, vol. 35, no. 4, pp. 828–839, 2014. View at Publisher · View at Google Scholar · View at Scopus
  48. M.-H. Teiten, F. Gaascht, M. Cronauer, E. Henry, M. Dicato, and M. Diederich, “Anti-proliferative potential of curcumin in androgen-dependent prostate cancer cells occurs through modulation of the Wingless signaling pathway,” International Journal of Oncology, vol. 38, no. 3, pp. 603–611, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. J. Lian, X. Wu, F. He et al., “A natural BH3 mimetic induces autophagy in apoptosis-resistant prostate cancer via modulating Bcl-2-Beclin1 interaction at endoplasmic reticulum,” Cell Death and Differentiation, vol. 18, no. 1, pp. 60–71, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Lian, Z. Ni, X. Dai et al., “Sorafenib sensitizes (-)-gossypol-induced growth suppression in androgen-independent prostate cancer cells via Mcl-1 inhibition and bak activation,” Molecular Cancer Therapeutics, vol. 11, no. 2, pp. 416–426, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. X. Q. Zhang, X. F. Huang, X. B. Hu et al., “Apogossypolone, a novel inhibitor of antiapoptotic Bcl-2 family proteins, induces autophagy of PC-3 and LNCaP prostate cancer cells in vitro,” Asian Journal of Andrology, vol. 12, no. 5, pp. 697–708, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. P. Chen, J. Yu, B. Chalmers et al., “Pharmacological ascorbate induces cytotoxicity in prostate cancer cells through ATP depletion and induction of autophagy,” Anti-Cancer Drugs, vol. 23, no. 4, pp. 437–444, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Tomasetti, L. Nocchi, J. Neuzil et al., “Alpha-tocopheryl succinate inhibits autophagic survival of prostate cancer cells induced by vitamin K3 and ascorbate to trigger cell death,” PLoS ONE, vol. 7, no. 12, Article ID e52263, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. D. Kumar, S. Shankar, and R. K. Srivastava, “Rottlerin induces autophagy and apoptosis in prostate cancer stem cells via PI3K/Akt/mTOR signaling pathway,” Cancer Letters, vol. 343, no. 2, pp. 179–189, 2014. View at Publisher · View at Google Scholar · View at Scopus
  55. D.-Y. Ouyang, L.-H. Zeng, H. Pan et al., “Piperine inhibits the proliferation of human prostate cancer cells via induction of cell cycle arrest and autophagy,” Food and Chemical Toxicology, vol. 60, pp. 424–430, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. P. Makhov, K. Golovine, E. Teper et al., “Piperlongumine promotes autophagy via inhibition of Akt/mTOR signalling and mediates cancer cell death,” British Journal of Cancer, vol. 110, no. 4, pp. 899–907, 2014. View at Publisher · View at Google Scholar · View at Scopus
  57. S. W. Shin, S. Y. Kim, and J.-W. Park, “Autophagy inhibition enhances ursolic acid-induced apoptosis in PC3 cells,” Biochimica et Biophysica Acta, vol. 1823, no. 2, pp. 451–457, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. H. Jiang, J. Sun, Q. Xu et al., “Marchantin M: a novel inhibitor of proteasome induces autophagic cell death in prostate cancer cells,” Cell Death and Disease, vol. 4, article e761, 2013. View at Publisher · View at Google Scholar · View at Scopus
  59. R.-J. Chen, C.-M. Hung, Y.-L. Chen, M.-D. Wu, G.-F. Yuan, and Y.-J. Wang, “Monascuspiloin induces apoptosis and autophagic cell death in human prostate cancer cells via the akt and AMPK signaling pathways,” Journal of Agricultural and Food Chemistry, vol. 60, no. 29, pp. 7185–7193, 2012. View at Publisher · View at Google Scholar · View at Scopus
  60. H.-W. Chiu, W.-H. Fang, Y.-L. Chen et al., “Monascuspiloin enhances the radiation sensitivity of human prostate cancer cells by stimulating endoplasmic reticulum stress and inducing autophagy,” PLoS ONE, vol. 7, no. 7, Article ID e40462, 2012. View at Publisher · View at Google Scholar · View at Scopus
  61. B. Liu, Q. Mao, M. Cao, and L. Xie, “Cruciferous vegetables intake and risk of prostate cancer: a meta-analysis,” International Journal of Urology, vol. 19, no. 2, pp. 134–141, 2012. View at Publisher · View at Google Scholar · View at Scopus
  62. R. Chan, K. Lok, and J. Woo, “Prostate cancer and vegetable consumption,” Molecular Nutrition and Food Research, vol. 53, no. 2, pp. 201–216, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. S. V. Singh and K. Singh, “Cancer chemoprevention with dietary isothiocyanates mature for clinical translational research,” Carcinogenesis, vol. 33, no. 10, pp. 1833–1842, 2012. View at Publisher · View at Google Scholar · View at Scopus
  64. J. D. Clarke, R. H. Dashwood, and E. Ho, “Multi-targeted prevention of cancer by sulforaphane,” Cancer Letters, vol. 269, no. 2, pp. 291–304, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. J. D. Brooks and V. Paton, “Potent induction of carcinogen defence enzymes with sulforaphane, a putative prostate cancer chemopreventive agent,” Prostate Cancer and Prostatic Diseases, vol. 2, supplement 3, p. S8, 1999. View at Google Scholar · View at Scopus
  66. J. D. Clarke, A. Hsu, Z. Yu, R. H. Dashwood, and E. Ho, “Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells,” Molecular Nutrition and Food Research, vol. 55, no. 7, pp. 999–1009, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. S. V. Singh, R. Warin, D. Xiao et al., “Sulforaphane inhibits prostate carcinogenesis and pulmonary metastasis in TRAMP mice in association with increased cytotoxicity of natural killer cells,” Cancer Research, vol. 69, no. 5, pp. 2117–2125, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. A. Basu and S. Haldar, “Dietary isothiocyanate mediated apoptosis of human cancer cells is associated with Bcl-xL phosphorylation,” International Journal of Oncology, vol. 33, no. 4, pp. 657–663, 2008. View at Publisher · View at Google Scholar · View at Scopus
  69. S. K. Srivastava, D. Xiao, K. L. Lew et al., “Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits growth of PC-3 human prostate cancer xenograft in vivo,” Carcinogenesis, vol. 24, no. 10, pp. 1665–1670, 2003. View at Publisher · View at Google Scholar · View at Scopus
  70. D. Xiao, S. K. Srivastava, K. L. Lew et al., “Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits proliferation of human prostate cancer cells by causing G2/M arrest and inducing apoptosis,” Carcinogenesis, vol. 24, no. 5, pp. 891–897, 2003. View at Publisher · View at Google Scholar · View at Scopus
  71. D. Xiao, A. Bommareddy, S.-H. Kim, A. Sehrawat, E.-R. Hahm, and S. V. Singh, “Benzyl isothiocyanate causes FoxO1-mediated autophagic death in human breast cancer cells,” PLoS ONE, vol. 7, no. 3, Article ID e32597, 2012. View at Publisher · View at Google Scholar · View at Scopus
  72. T. Nishikawa, N. H. Tsuno, Y. Okaji et al., “Inhibition of autophagy potentiates sulforaphane-induced apoptosis in human colon cancer cells,” Annals of Surgical Oncology, vol. 17, no. 2, pp. 592–602, 2010. View at Publisher · View at Google Scholar · View at Scopus
  73. S. Kanematsu, N. Uehara, H. Miki et al., “Autophagy inhibition enhances sulforaphane-induced apoptosis in human breast cancer cells,” Anticancer Research, vol. 30, no. 9, pp. 3381–3390, 2010. View at Google Scholar · View at Scopus
  74. P. Naumann, F. Fortunato, H. Zentgraf, M. W. Büchler, I. Herr, and J. Werner, “Autophagy and cell death signaling following dietary sulforaphane act independently of each other and require oxidative stress in pancreatic cancer,” International Journal of Oncology, vol. 39, no. 1, pp. 101–109, 2011. View at Publisher · View at Google Scholar · View at Scopus
  75. S. V. Singh, A. Herman-Antosiewicz, A. V. Singh et al., “Sulforaphane-induced G2/M phase cell cycle arrest involves checkpoint kinase 2-mediated phosphorylation of cell division cycle 25C,” The Journal of Biological Chemistry, vol. 279, no. 24, pp. 25813–25822, 2004. View at Publisher · View at Google Scholar · View at Scopus
  76. S. Choi, K. L. Lew, H. Xiao et al., “D,L-Sulforaphane-induced cell death in human prostate cancer cells is regulated by inhibitor of apoptosis family proteins and Apaf-1,” Carcinogenesis, vol. 28, no. 1, pp. 151–162, 2007. View at Publisher · View at Google Scholar · View at Scopus
  77. S. Choi and S. V. Singh, “Bax and Bak are required for apoptosis induction by sulforaphane, a cruciferous vegetable-derived cancer chemopreventive agent,” Cancer Research, vol. 65, no. 5, pp. 2035–2043, 2005. View at Publisher · View at Google Scholar · View at Scopus
  78. A. V. Singh, D. Xiao, K. L. Lew, R. Dhir, and S. V. Singh, “Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth PC-3 xenografts in vivo,” Carcinogenesis, vol. 25, no. 1, pp. 83–90, 2004. View at Publisher · View at Google Scholar · View at Scopus
  79. M. C. Myzak, P. Tong, W.-M. Dashwood, R. H. Dashwood, and E. Ho, “Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects,” Experimental Biology and Medicine, vol. 232, no. 2, pp. 227–234, 2007. View at Google Scholar · View at Scopus
  80. S. V. Singh, S. K. Srivastava, S. Choi et al., “Sulforaphane-induced cell death in human prostate cancer cells is initiated by reactive oxygen species,” Journal of Biological Chemistry, vol. 280, no. 20, pp. 19911–19924, 2005. View at Publisher · View at Google Scholar · View at Scopus
  81. K. C. Liu, Y. A. T. Huang, P. P. Wu et al., “The roles of AIF and Endo G in the apoptotic effects of benzyl isothiocyanate on DU 145 human prostate cancer cells via the mitochondrial signaling pathway,” International Journal of Oncology, vol. 38, no. 3, pp. 787–796, 2011. View at Publisher · View at Google Scholar · View at Scopus
  82. D. Xiao, C. S. Jonhson, D. L. Trump, and S. V. Singh, “Proteasome-mediated degradation of cell division cycle 25C and cyclin-dependent kinase 1 in phenethyl isothiocyanate-induced G2-M-phase cell cycle arrest in PC-3 human prostate cancer cells,” Molecular Cancer Therapeutics, vol. 3, no. 5, pp. 567–575, 2004. View at Google Scholar · View at Scopus
  83. D. Xiao, Y. Zeng, S. Choi, K. L. Lew, J. B. Nelson, and S. V. Singh, “Caspase-dependent apoptosis induction by phenethyl isothiocyanate, a cruciferous vegetable-derived cancer chemopreventive agent, is mediated by Bak and Bax,” Clinical Cancer Research, vol. 11, no. 7, pp. 2670–2679, 2005. View at Publisher · View at Google Scholar · View at Scopus
  84. D. Xiao, K. L. Lew, Y. Zeng et al., “Phenethyl isothiocyanate-induced apoptosis in PC-3 human prostate cancer cells is mediated by reactive oxygen species-dependent disruption of the mitochondrial membrane potential,” Carcinogenesis, vol. 27, no. 11, pp. 2223–2234, 2006. View at Publisher · View at Google Scholar · View at Scopus
  85. A. Barve, T. O. Khor, X. Hao et al., “Murine prostate cancer inhibition by dietary phytochemicals—curcumin and phenyethylisothiocyanate,” Pharmaceutical Research, vol. 25, no. 9, pp. 2181–2189, 2008. View at Publisher · View at Google Scholar · View at Scopus
  86. N.-Y. Tang, Y.-T. Huang, C.-S. Yu et al., “Phenethyl isothiocyanate (PEITC) promotes G2/M phase arrest via p53 expression and induces apoptosis through caspase- and mitochondria-dependent signaling pathways in human prostate cancer DU 145 cells,” Anticancer Research, vol. 31, no. 5, pp. 1691–1702, 2011. View at Google Scholar · View at Scopus
  87. C. Xue, H. A. Pasolli, I. Piscopo et al., “Mitochondrial structure alteration in human prostate cancer cells upon initial interaction with a chemopreventive agent phenethyl isothiocyanate,” Cancer Cell International, vol. 14, no. 1, article 30, 2014. View at Publisher · View at Google Scholar · View at Scopus
  88. S. Cimino, G. Sortino, V. Favilla et al., “Polyphenols: key issues involved in chemoprevention of prostate cancer,” Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 632959, 8 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  89. A. Bommareddy, W. Eggleston, S. Prelewicz et al., “Chemoprevention of prostate cancer by major dietary phytochemicals,” Anticancer Research, vol. 33, no. 10, pp. 4163–4174, 2013. View at Google Scholar · View at Scopus
  90. N. Hasima and B. Ozpolat, “Regulation of autophagy by polyphenolic compounds as a potential therapeutic strategy for cancer,” Cell Death and Disease, vol. 5, no. 11, Article ID e1509, 2014. View at Publisher · View at Google Scholar
  91. M. Jang, L. Cai, G. O. Udeani et al., “Cancer chemopreventive activity of resveratrol, a natural product derived from grapes,” Science, vol. 275, no. 5297, pp. 218–220, 1997. View at Publisher · View at Google Scholar · View at Scopus
  92. L. G. Carter, J. A. D'Orazio, and K. J. Pearson, “Resveratrol and cancer: focus on in vivo evidence,” Endocrine Related Cancer, vol. 21, no. 3, pp. R209–R225, 2014. View at Publisher · View at Google Scholar
  93. M. Jasiński, L. Jasińska, and M. Ogrodowczyk, “Resveratrol in prostate diseases—a short review,” Central European Journal of Urology, vol. 66, no. 2, pp. 144–149, 2013. View at Google Scholar · View at Scopus
  94. C. K. Singh, M. A. Ndiaye, and N. Ahmad, “Resveratrol and cancer: challenges for clinical translation,” Biochimica et Biophysica Acta—Molecular Basis of Disease, 2014. View at Publisher · View at Google Scholar
  95. M. Wang, T. Yu, C. Zhu et al., “Resveratrol triggers protective autophagy through the ceramide/Akt/mTOR pathway in melanoma B16 cells,” Nutrition and Cancer, vol. 66, no. 3, pp. 435–440, 2014. View at Publisher · View at Google Scholar · View at Scopus
  96. N. F. Trincheri, C. Follo, G. Nicotra, C. Peracchio, R. Castino, and C. Isidoro, “Resveratrol-induced apoptosis depends on the lipid kinase activity of Vps34 and on the formation of autophagolysosomes,” Carcinogenesis, vol. 29, no. 2, pp. 381–389, 2008. View at Publisher · View at Google Scholar · View at Scopus
  97. N. Khan, V. M. Adhami, and H. Mukhtar, “Review: green tea polyphenols in chemoprevention of prostate cancer: preclinical and clinical studies,” Nutrition and Cancer, vol. 61, no. 6, pp. 836–841, 2009. View at Publisher · View at Google Scholar · View at Scopus
  98. J. D. Lambert, “Does tea prevent cancer? Evidence from laboratory and human intervention studies,” The American Journal of Clinical Nutrition, vol. 98, supplement 6, pp. 1667S–1675S, 2013. View at Publisher · View at Google Scholar · View at Scopus
  99. C. S. Yang, J. Ju, G. Lu et al., “Cancer prevention by tea and tea polyphenols,” Asia Pacific Journal of Clinical Nutrition, vol. 17, supplement 1, pp. 245–248, 2008. View at Google Scholar
  100. P. Davalli, F. Rizzi, A. Caporali et al., “Anticancer activity of green tea polyphenols in prostate gland,” Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 984219, 18 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  101. J. J. Johnson, H. H. Bailey, and H. Mukhtar, “Green tea polyphenols for prostate cancer chemoprevention: a translational perspective,” Phytomedicine, vol. 17, no. 1, pp. 3–13, 2010. View at Publisher · View at Google Scholar · View at Scopus
  102. V. Venkateswaran and L. H. Klotz, “Diet and prostate cancer: mechanisms of action and implications for chemoprevention,” Nature Reviews Urology, vol. 7, no. 8, pp. 442–453, 2010. View at Publisher · View at Google Scholar · View at Scopus
  103. S. Gupta, K. Hastak, N. Ahmad, J. S. Lewin, and H. Mukhtar, “Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 18, pp. 10350–10355, 2001. View at Publisher · View at Google Scholar · View at Scopus
  104. C. E. Harper, B. B. Patel, J. Wang, I. A. Eltoum, and C. A. Lamartiniere, “Epigallocatechin-3-gallate suppresses early stage, but not late stage prostate cancer inTRAMP mice: mechanisms of action,” Prostate, vol. 67, no. 14, pp. 1576–1589, 2007. View at Publisher · View at Google Scholar · View at Scopus
  105. S. M. Henning, P. Wang, J. Said et al., “Polyphenols in brewed green tea inhibit prostate tumor xenograft growth by localizing to the tumor and decreasing oxidative stress and angiogenesis,” Journal of Nutritional Biochemistry, vol. 23, no. 11, pp. 1537–1542, 2012. View at Publisher · View at Google Scholar · View at Scopus
  106. S. Bettuzzi, M. Brausi, F. Rizzi, G. Castagnetti, G. Peracchia, and A. Corti, “Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study,” Cancer Research, vol. 66, no. 2, pp. 1234–1240, 2006. View at Publisher · View at Google Scholar · View at Scopus
  107. J. McLarty, R. L. H. Bigelow, M. Smith, D. Elmajian, M. Ankem, and J. A. Cardelli, “Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro,” Cancer Prevention Research, vol. 2, no. 7, pp. 673–682, 2009. View at Publisher · View at Google Scholar · View at Scopus
  108. A. Jatoi, N. Ellison, P. A. Burch et al., “A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma,” Cancer, vol. 97, no. 6, pp. 1442–1446, 2003. View at Publisher · View at Google Scholar · View at Scopus
  109. E. Choan, R. Segal, D. Jonker et al., “A prospective clinical trial of green tea for hormone refractory prostate cancer: an evaluation of the complementary/alternative therapy approach,” Urologic Oncology, vol. 23, no. 2, pp. 108–113, 2005. View at Publisher · View at Google Scholar · View at Scopus
  110. M. M. Nguyen, F. R. Ahmann, R. B. Nagle et al., “Randomized, double-blind, placebo-controlled trial of polyphenon E in prostate cancer patients before prostatectomy: evaluation of potential chemopreventive activities,” Cancer Prevention Research, vol. 5, no. 2, pp. 290–298, 2012. View at Publisher · View at Google Scholar · View at Scopus
  111. M. Brausi, F. Rizzi, and S. Bettuzzi, “Chemoprevention of human prostate cancer by green tea catechins: two years later. A follow-up update,” European Urology, vol. 54, no. 2, pp. 472–473, 2008. View at Publisher · View at Google Scholar · View at Scopus
  112. H.-S. Kim, M. J. Quon, and J.-A. Kim, “New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate,” Redox Biology, vol. 2, pp. 187–195, 2014. View at Publisher · View at Google Scholar · View at Scopus
  113. J. M. Witkin and X. Li, “Curcumin, an active constiuent of the ancient medicinal herb Curcuma longa L.: some uses and the establishment and biological basis of medical efficacy,” CNS & Neurol Disord—Drug Targets, vol. 12, no. 4, pp. 487–497, 2013. View at Publisher · View at Google Scholar · View at Scopus
  114. A. H. Rahmani, M. A. Al Zohairy, S. M. Aly, and M. A. Khan, “Curcumin: a potential candidate in prevention of cancer via modulation of molecular pathways,” BioMed Research International, vol. 2014, Article ID 761608, 15 pages, 2014. View at Publisher · View at Google Scholar
  115. S. C. Gupta, S. Prasad, J. H. Kim et al., “Multitargeting by curcumin as revealed by molecular interaction studies,” Natural Product Reports, vol. 28, no. 12, pp. 1937–1955, 2011. View at Publisher · View at Google Scholar · View at Scopus
  116. K. Zikaki, I.-K. Aggeli, C. Gaitanaki, and I. Beis, “Curcumin induces the apoptotic intrinsic pathway via upregulation of reactive oxygen species and JNKs in H9c2 cardiac myoblasts,” Apoptosis, vol. 19, no. 6, pp. 958–974, 2014. View at Publisher · View at Google Scholar · View at Scopus
  117. G. O'Sullivan-Coyne, G. C. O'Sullivan, T. R. O'Donovan, K. Piwocka, and S. L. McKenna, “Curcumin induces apoptosis-independent death in oesophageal cancer cells,” British Journal of Cancer, vol. 101, no. 9, pp. 1585–1595, 2009. View at Publisher · View at Google Scholar · View at Scopus
  118. K. Wolanin, A. Magalska, G. Mosieniak et al., “Curcumin affects components of the chromosomal passenger complex and induces mitotic catastrophe in apoptosis-resistant Bcr-Abl-expressing cells,” Molecular Cancer Research, vol. 4, no. 7, pp. 457–469, 2006. View at Publisher · View at Google Scholar · View at Scopus
  119. H. Aoki, Y. Takada, S. Kondo, R. Sawaya, B. B. Aggarwal, and Y. Kondo, “Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of akt and extracellular signal-regulated kinase signaling pathways,” Molecular Pharmacology, vol. 72, no. 1, pp. 29–39, 2007. View at Publisher · View at Google Scholar · View at Scopus
  120. G. Z. Zhou, S. N. Zhang, L. Zhang, G. C. Sun, and X.-B. Chen, “A synthetic curcumin derivative hydrazinobenzoylcurcumin induces autophagy in A549 lung cancer cells,” Pharmaceutical Biology, vol. 52, no. 1, pp. 111–116, 2014. View at Publisher · View at Google Scholar · View at Scopus
  121. J. Y. Kim, T. J. Cho, B. H. Woo et al., “Curcumin-induced autophagy contributes to the decreased survival of oral cancer cells,” Archives of Oral Biology, vol. 57, no. 8, pp. 1018–1025, 2012. View at Publisher · View at Google Scholar · View at Scopus
  122. B. Li, T. Takeda, K. Tsuiji et al., “Curcumin induces cross-regulation between autophagy and apoptosis in uterine leiomyosarcoma cells,” International Journal of Gynecological Cancer, vol. 23, no. 5, pp. 803–808, 2013. View at Publisher · View at Google Scholar · View at Scopus
  123. W. Zhuang, L. Long, B. Zheng et al., “Curcumin promotes differentiation of glioma-initiating cells by inducing autophagy,” Cancer Science, vol. 103, no. 4, pp. 684–690, 2012. View at Publisher · View at Google Scholar · View at Scopus
  124. G. Mosieniak, M. Adamowicz, O. Alster et al., “Curcumin induces permanent growth arrest of human colon cancer cells: link between senescence and autophagy,” Mechanisms of Ageing and Development, vol. 133, no. 6, pp. 444–455, 2012. View at Publisher · View at Google Scholar · View at Scopus
  125. C. Kantara, M. O'Connell, S. Sarkar, S. Moya, R. Ullrich, and P. Singh, “Curcumin promotes autophagic survival of a subset of colon cancer stem cells, which are ablated by DCLK1-siRNA,” Cancer Research, vol. 74, no. 9, pp. 2487–2498, 2014. View at Publisher · View at Google Scholar · View at Scopus
  126. S. Patschan, J. Chen, A. Polotskaia et al., “Lipid mediators of autophagy in stress-induced premature senescence of endothelial cells,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 294, no. 3, pp. H1119–H1129, 2008. View at Publisher · View at Google Scholar · View at Scopus
  127. L. Yu and S. Liu, “Autophagy contributes to modulating the cytotoxicities of Bcl-2 homology domain-3 mimetics,” Seminars in Cancer Biology, vol. 23, no. 6, part B, pp. 553–560, 2013. View at Publisher · View at Google Scholar · View at Scopus
  128. X. Pang, Y. Wu, B. Lu et al., “(-)-gossypol suppresses the growth of human prostate cancer xenografts via modulating VEGF signaling-mediated angiogenesis,” Molecular Cancer Therapeutics, vol. 10, no. 5, pp. 795–805, 2011. View at Publisher · View at Google Scholar · View at Scopus
  129. Y. Meng, W. Tang, Y. Dai et al., “Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa,” Molecular Cancer Therapeutics, vol. 7, no. 7, pp. 2192–2202, 2008. View at Publisher · View at Google Scholar · View at Scopus
  130. G. Liu, W. K. Kelly, G. Wilding, L. Leopold, K. Brill, and B. Somer, “An open-label, multicenter, phase I/II study of single-agent AT-101 in men with castrate-resistant prostate cancer,” Clinical Cancer Research, vol. 15, no. 9, pp. 3172–3176, 2009. View at Publisher · View at Google Scholar · View at Scopus
  131. G. Sonpavde, V. Matveev, J. M. Burke et al., “Randomized phase II trial of docetaxel plus prednisone in combination with placebo or AT-101, an oral small molecule Bcl-2 family antagonist, as first-line therapy for metastatic castration-resistant prostate cancer,” Annals of Oncology, vol. 23, no. 7, Article ID mdr555, pp. 1803–1808, 2012. View at Publisher · View at Google Scholar · View at Scopus
  132. D. W. Lamson and S. M. Plaza, “The anticancer effects of vitamin K,” Alternative Medicine Review, vol. 8, no. 3, pp. 303–318, 2003. View at Google Scholar · View at Scopus
  133. J. Du, J. J. Cullen, and G. R. Buettner, “Ascorbic acid: chemistry, biology and the treatment of cancer,” Biochimica et Biophysica Acta, vol. 1826, no. 2, pp. 443–457, 2012. View at Publisher · View at Google Scholar · View at Scopus
  134. T. Yokoyama, K. Miyazawa, M. Naito et al., “Vitamin K2 induces autophagy and apoptosis simultaneously in leukemia cells,” Autophagy, vol. 4, no. 5, pp. 629–640, 2008. View at Publisher · View at Google Scholar · View at Scopus
  135. S. Ohtani, A. Iwamaru, W. Deng et al., “Tumor suppressor 101F6 and ascorbate synergistically and selectively inhibit non-small cell lung cancer growth by caspase-independent apoptosis and autophagy,” Cancer Research, vol. 67, no. 13, pp. 6293–6303, 2007. View at Publisher · View at Google Scholar · View at Scopus
  136. S.-W. Hong, S.-H. Lee, J.-H. Moon et al., “SVCT-2 in breast cancer acts as an indicator for L-ascorbate treatment,” Oncogene, vol. 32, no. 12, pp. 1508–1517, 2013. View at Publisher · View at Google Scholar · View at Scopus
  137. H. Kawakita, A. Tsuchida, K. Miyazawa et al., “Growth inhibitory effects of vitamin K2 on colon cancer cell lines via different types of cell death including autophagy and apoptosis,” International Journal of Molecular Medicine, vol. 23, no. 6, pp. 709–716, 2009. View at Publisher · View at Google Scholar · View at Scopus
  138. M. Enomoto, A. Tsuchida, K. Miyazawa et al., “Vitamin K2-induced cell growth inhibition via autophagy formation in cholangiocellular carcinoma cell lines,” International Journal of Molecular Medicine, vol. 20, no. 6, pp. 801–808, 2007. View at Google Scholar · View at Scopus
  139. C. Yang and L.-O. Han, “Knockdown of Beclin 1 inhibits vitamin K3-induced autophagy, but promotes apoptosis of human hepatoma SMMC-7721 cells,” Molecular Medicine Reports, vol. 3, no. 5, pp. 801–807, 2010. View at Publisher · View at Google Scholar · View at Scopus
  140. P. M. Herst, K. W. R. Broadley, J. L. Harper, and M. J. McConnell, “Pharmacological concentrations of ascorbate radiosensitize glioblastoma multiforme primary cells by increasing oxidative DNA damage and inhibiting G2/M arrest,” Free Radical Biology and Medicine, vol. 52, no. 8, pp. 1486–1493, 2012. View at Publisher · View at Google Scholar · View at Scopus
  141. M. Menon, C. Maramag, R. K. Malhotra, and L. Seethalakshmi, “Effect of vitamin C on androgen independent prostate cancer cells (PC3 and Mat-Ly-Lu) in vitro: involvement of reactive oxygen species-effect on cell number, viability and DNA synthesis,” Cancer Biochemistry Biophysics, vol. 16, no. 1-2, pp. 17–30, 1998. View at Google Scholar
  142. M. Venugopal, J. M. Jamison, J. Gilloteaux et al., “Synergistic antitumour activity of vitamins C and K3 against human prostate carcinoma cell lines,” Cell Biology International, vol. 20, no. 12, pp. 787–797, 1996. View at Publisher · View at Google Scholar · View at Scopus
  143. M. Venugopal, J. M. Jamison, J. Gilloteaux et al., “Synergistic antitumor activity of vitamins C and K3 on human urologic tumor cell lines,” Life Sciences, vol. 59, no. 17, pp. 1389–1400, 1996. View at Publisher · View at Google Scholar · View at Scopus
  144. M. Tomasetti, E. Strafella, S. Staffolani, L. Santarelli, J. Neuzil, and R. Guerrieri, “α-Tocopheryl succinate promotes selective cell death induced by vitamin K3 in combination with ascorbate,” British Journal of Cancer, vol. 102, no. 8, pp. 1224–1234, 2010. View at Publisher · View at Google Scholar · View at Scopus
  145. H. S. Taper, J. M. Jamison, J. Gilloteaux, C. A. Gwin, T. Gordon, and J. L. Summers, “In vivo reactivation of DNases in implanted human prostate tumors after administration of a vitamin C/K3 combination,” Journal of Histochemistry and Cytochemistry, vol. 49, no. 1, pp. 109–119, 2001. View at Publisher · View at Google Scholar · View at Scopus
  146. J. M. Jamison, J. Gilloteaux, H. S. Taper, and J. L. Summers, “Evaluation of the in vitro and in vivo antitumor activities of vitamin C and K-3 combinations against human prostate cancer,” Journal of Nutrition, vol. 131, supplement 1, pp. 158S–160S, 2001. View at Google Scholar · View at Scopus
  147. E. Maioli, C. Torricelli, and G. Valacchi, “Rottlerin and cancer: novel evidence and mechanisms,” The Scientific World Journal, vol. 2012, Article ID 350826, 11 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  148. P. Makhov, K. Golovine, D. Canter et al., “Co-administration of piperine and docetaxel results in improved anti-tumor efficacy via inhibition of CYP3A4 activity,” Prostate, vol. 72, no. 6, pp. 661–667, 2012. View at Publisher · View at Google Scholar · View at Scopus
  149. A. Samykutty, A. V. Shetty, G. Dakshinamoorthy et al., “Piperine, a bioactive component of pepper spice exerts therapeutic effects on androgen dependent and androgen independent prostate cancer cells,” PLoS ONE, vol. 8, no. 6, Article ID e65889, 2013. View at Publisher · View at Google Scholar · View at Scopus
  150. S. Ginzburg, K. V. Golovine, P. B. Makhov, R. G. Uzzo, A. Kutikov, and V. M. Kolenko, “Piperlongumine inhibits NF-κB activity and attenuates aggressive growth characteristics of prostate cancer cells,” The Prostate, vol. 74, no. 2, pp. 177–186, 2014. View at Publisher · View at Google Scholar · View at Scopus
  151. T. Rabi and S. Gupta, “Dietary terpenoids and prostate cancer chemoprevention,” Frontiers in Bioscience, vol. 13, no. 9, pp. 3457–3469, 2008. View at Publisher · View at Google Scholar · View at Scopus
  152. Y. Zhang, C. Kong, Y. Zeng et al., “Ursolic acid induces PC-3 cell apoptosis via activation of JNK and inhibition of Akt pathways in vitro,” Molecular Carcinogenesis, vol. 49, no. 4, pp. 374–385, 2010. View at Publisher · View at Google Scholar · View at Scopus
  153. M. K. Shanmugam, T. H. Ong, A. P. Kumar et al., “Ursolic acid inhibits the initiation, progression of prostate cancer and prolongs the survival of TRAMP mice by modulating pro-inflammatory pathways,” PLoS ONE, vol. 7, no. 3, Article ID e32476, 2012. View at Publisher · View at Google Scholar · View at Scopus
  154. S. Leng, Y. Hao, D. Du et al., “Ursolic acid promotes cancer cell death by inducing Atg5-dependent autophagy,” International Journal of Cancer, vol. 133, no. 12, pp. 2781–2790, 2013. View at Publisher · View at Google Scholar · View at Scopus
  155. C. Zhao, S. Yin, Y. Dong et al., “Autophagy-dependent EIF2AK3 activation compromises ursolic acid-induced apoptosis through upregulation of MCL1 in MCF-7 human breast cancer cells,” Autophagy, vol. 9, no. 2, pp. 196–207, 2013. View at Publisher · View at Google Scholar · View at Scopus
  156. C. P. R. Xavier, C. F. Lima, D. F. N. Pedro, J. M. Wilson, K. Kristiansen, and C. Pereira-Wilson, “Ursolic acid induces cell death and modulates autophagy through JNK pathway in apoptosis-resistant colorectal cancer cells,” Journal of Nutritional Biochemistry, vol. 24, no. 4, pp. 706–712, 2013. View at Publisher · View at Google Scholar · View at Scopus
  157. L. Niu, J. Deng, F. Zhu et al., “Anti-inflammatory effect of Marchantin M contributes to sensitization of prostate cancer cells to docetaxel,” Cancer Letters, vol. 348, no. 1-2, pp. 126–134, 2014. View at Publisher · View at Google Scholar · View at Scopus
  158. A.-H. Xu, Z.-M. Hu, J.-B. Qu et al., “Cyclic bisbibenzyls induce growth arrest and apoptosis of human prostate cancer PC3 cells,” Acta Pharmacologica Sinica, vol. 31, no. 5, pp. 609–615, 2010. View at Publisher · View at Google Scholar · View at Scopus
  159. P. Patakova, “Monascus secondary metabolites: production and biological activity,” Journal of Industrial Microbiology and Biotechnology, vol. 40, no. 2, pp. 169–181, 2013. View at Publisher · View at Google Scholar · View at Scopus
  160. W.-H. Hsu and T.-M. Pan, “Monascus purpureus-fermented products and oral cancer: a review,” Applied Microbiology and Biotechnology, vol. 93, no. 5, pp. 1831–1842, 2012. View at Publisher · View at Google Scholar · View at Scopus